| 前收市價 | 0.6000 |
| 開市 | 0.6000 |
| 買盤 | 0.0000 |
| 賣出價 | 1.5000 |
| 拍板 | 4.00 |
| 到期日 | 2024-07-05 |
| 今日波幅 | 0.6000 - 0.6000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 10 |
Insider MonkeyIs Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?
We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ:EDIT) stands against the other biotech penny stocks. Biotech Stocks in 2024: Growth Prospects, Key Players, and Investment Opportunities In 2024, the healthcare industry has […]
- Insider Monkey
What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with Highest Upside Potential?
We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this article, we are going to take a look at where Editas Medicine, Inc. (NASDAQ:EDIT) stands against the other small-cap stocks. Small-cap stocks are companies with a market capitalization of somewhere between $250 million and $2 billion. They are usually […]
InvestorPlaceRags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Gene editing is a game-changer. With it, we can remove cells from your body, edit them, and then reintroduce them back into the body. All to treat cancers, blood issues, blindness, cystic fibrosis, and muscular dystrophy. All of which is creating substantial opportunities for some of the leading gene editing stocks. What’s more exciting is companies like Profluent Bio “leveraged artificial intelligence to design an open-source gene editor called OpenCRISPR-1, demonstrating the technology can be
